During the past decade, Public Central Hospital of Matto Ishikawa conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Public Central Hospital of Matto Ishikawa" are "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Atrial Fibrillation" (1 trials), "End Stage Renal Disease Requiring Hemodialysis" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Public Central Hospital of Matto Ishikawa" in a lesser frequency.

Most popular intervention types in "Public Central Hospital of Matto Ishikawa" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "Placebo" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Public Central Hospital of Matto Ishikawa" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Public Central Hospital of Matto Ishikawa". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Public Central Hospital of Matto Ishikawa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Public Central Hospital of Matto Ishikawa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".